NATIONAL POLICY ON CHEMOTHERAPY SAFETY (CHEMOSAFE)

Simple item page
dc.contributor.authorFederal Ministry of Health
dc.date.accessioned2023-01-30T14:33:43Z
dc.date.available2023-01-30T14:33:43Z
dc.date.issued2021-06
dc.descriptionTable of Contents........................................................................................................................i List of Figures.......................................................................................................................... iii List of Tables ............................................................................................................................iv Foreword....................................................................................................................................v Acknowledgement ...................................................................................................................vii List of Contributors................................................................................................................ viii Acronyms / Abbreviations........................................................................................................ix 1.0 BACKGROUND ............................................................................................................1 1.1 Introduction .................................................................................................................1 1.2 Rationale for ChemoSafe Policy.................................................................................2 1.3 Goal and Objectives....................................................................................................4 1.3.1 Goal...........................................................................................................................4 1.3.2 Objectives .................................................................................................................4 1.4 Scope of the Policy......................................................................................................4 1.5 Policy Development Process.......................................................................................5 1.6 Updating......................................................................................................................5 2.0 POLICY FRAMEWORK ELEMENTS / THEMATIC AREAS ...................................6 2.1 The Environment.........................................................................................................6 2.1.1 Segregation of Chemotherapy Administration Area............................................6 2.1.2 Infrastructure (safety cabinets and compounding equipment).............................6 2.2 Supply Chain...............................................................................................................9 2.2.1 Transportation......................................................................................................9 2.2.2 Receiving and storage of Chemotherapy .............................................................9 2.2.3 Handling – compounding and dispensing..........................................................10 2.2.4 Checks required before Chemotherapy Administration ....................................10 2.3 Patient Care ...............................................................................................................11 2.3.1 Patient safety......................................................................................................11 2.3.2 Sources of exposure to cytotoxic medicines on health workers........................11 2.3.3 Disposal of Drug Contaminated Materials ........................................................12 2.4 Practitioner’s Responsibilities...................................................................................12 2.4.1 Training and Information Dissemination...........................................................13 2.4.2 Recommended safety precautions for practitioners (Oncology Doctors, Pharmacist, Nurses, Assistants and Hygienists)...............................13 2.4.3 Pregnancy, nursing or planning to become pregnant................19 2.4.4 Employee Information..................................19 2.4.5. Record Keeping......................................19 2.5 Capacity Building..................................19 2.5.1 Employee Training...........................20 2.6 monotoring and Evaluation................... 20 2.7 funding.........................................................21 3.0 Annexures.............................................23 3.1 Definition of terms................................23 3.2 Essential Medicine list for cancers.................23 4.0 References.................................................28
dc.description.abstractThe Federal Ministry of Health is committed to making all forms of cancer treatment more accessible and affordable in Nigeria. This underscores the collaboration currently in place to increase access to quality cancer care services at markedly reduced cost across the country. The Ministry is also paying particular attention towards improving access to radiotherapy services as well as improved expertise for surgical interventions nationwide.
dc.identifier.urihttps://nigeriareposit.nln.gov.ng/handle/20.500.14186/504
dc.language.isoen_US
dc.publisherFederal Ministry of Health
dc.titleNATIONAL POLICY ON CHEMOTHERAPY SAFETY (CHEMOSAFE)
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
NATIONAL CHEMOSAFE POLICY - 29 June (1)-1.pdf
Size:
699.5 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.82 KB
Format:
Item-specific license agreed to upon submission
Description:
Download
Collections
Annual Reports